Sibylle Moltzen Lenz
Keine laufenden Positionen mehr
Profil
Sibylle Moltzen Lenz served as the Chief Executive Officer of Alligator Bioscience AB from 2010 to 2015.
She also worked as a Director at Karo Healthcare AB from 2013 to 2015.
Prior to that, she was the Vice President of Corporate Business Development at Dako ApS from 2008 to 2010.
She was also a Principal at H.
Lundbeck A.
Dr. Moltzen Lenz holds a doctorate degree from the University of Copenhagen.
Ehemalige bekannte Positionen von Sibylle Moltzen Lenz
| Unternehmen | Position | Ende |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Vorstandsvorsitzender | 01.07.2015 |
| KARO PHARMA AB (PUBL) | Direktor/Vorstandsmitglied | 01.05.2015 |
Dako ApS
 Dako ApS Electronic Equipment/InstrumentsElectronic Technology Part of Agilent Technologies, Inc., Dako ApS is a Danish company that designs and manufactures cancer diagnostic systems. The company is based in Glostrup, Denmark. | Corporate Officer/Principal | 01.01.2010 |
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
Ausbildung von Sibylle Moltzen Lenz
| University of Copenhagen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| KARO PHARMA AB (PUBL) | Health Technology |
| H. LUNDBECK A/S | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Dako ApS
Dako ApS Electronic Equipment/InstrumentsElectronic Technology Part of Agilent Technologies, Inc., Dako ApS is a Danish company that designs and manufactures cancer diagnostic systems. The company is based in Glostrup, Denmark. | Electronic Technology |
